Skip to Main Content

Author Details

Jesse M Zaretsky
University of California los angeles
2007
21
19
PMIDPaper TitleJournal TitlePublished Year
32467343Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.Cancer Discov2020
32467343Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade.Cancer Discov2020
33055240Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.Sci Transl Med2020
34368780PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
35122015Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
35121931Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.Nat Cancer2020
35122015Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
35121931Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.Nat Cancer2020
34368780PAK4 inhibition improves PD-1 blockade immunotherapy.Nat Cancer2020
33055240Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.Sci Transl Med2020
30700902T cell antigen discovery via signaling and antigen-presenting bifunctional receptors.Nat Methods2019
31825850Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.Cell Rep2019
30700903T cell antigen discovery via trogocytosis.Nat Methods2019
30700902T cell antigen discovery via signaling and antigen-presenting bifunctional receptors.Nat Methods2019
31484081Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood.Cell Rep2019
31825850Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.Cell Rep2019
31484081Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood.Cell Rep2019
30700903T cell antigen discovery via trogocytosis.Nat Methods2019
29320474High response rate to PD-1 blockade in desmoplastic melanomas.Nature2018
29510987Genetic Mechanisms of Immune Evasion in Colorectal Cancer.Cancer Discov2018
29320474High response rate to PD-1 blockade in desmoplastic melanomas.Nature2018
29510987Genetic Mechanisms of Immune Evasion in Colorectal Cancer.Cancer Discov2018
27903500Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.Cancer Discov2017
28808226ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways.Nat Commun2017
28494868Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.Cell Rep2017
28129544Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Cell2017
27903500Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.Cancer Discov2017
28129544Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Cell2017
28494868Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.Cell Rep2017
28808226ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways.Nat Commun2017
26997480Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Cell2016
27433843Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.N Engl J Med2016
26787823PD-1 Blockade Expands Intratumoral Memory T Cells.Cancer Immunol Res2016
26997480Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.Cell2016
27589875Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.Cancer Immunol Res2016
27589875Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.Cancer Immunol Res2016
27433843Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.N Engl J Med2016
26787823PD-1 Blockade Expands Intratumoral Memory T Cells.Cancer Immunol Res2016
25409260Genetic basis for clinical response to CTLA-4 blockade in melanoma.N Engl J Med2014
25409260Genetic basis for clinical response to CTLA-4 blockade in melanoma.N Engl J Med2014
17720911Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes.Genetics2007
17720911Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes.Genetics2007
  • 1 - 42 of 42

Recommended Authors

Memorial Sloan Kettering Cancer Center (MSKCC)
Career Start Year 2015
Number of shared co-authors 2
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
Columbia University
Career Start Year 2014
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2012
Number of shared co-authors 0
Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 2009
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 9
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 2
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 3
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2006
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 2
MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 4
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 8
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 3
University of California san francisco
Career Start Year 1993
Number of shared co-authors 5
University of Colorado Anschutz Medical Campus
Career Start Year 1990
Number of shared co-authors 5
University of Virginia
Career Start Year 1987
Number of shared co-authors 9
University of Melbourne
Career Start Year 1986
Number of shared co-authors 5
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 4
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 7
UPMC Hillman Cancer Center
Career Start Year 1974
Number of shared co-authors 7

Collaborators

University of California Los Angeles (university of california los angeles)
Co-authored papers 20
Jonsson Comprehensive Cancer Center, University of California Los Angeles
Co-authored papers 6
Stanford Cancer Institute, Stanford School of Medicine
Co-authored papers 5
Institute of Systems Biology, University of Washington
Co-authored papers 3
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Co-authored papers 2
University of California, Los Angeles (university of california los angeles)
Co-authored papers 2
Fred Hutchinson Cancer Research Center, USA Clinical Research Division
Co-authored papers 2
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
David Geffen School of Medicine at the University of California los angeles
Co-authored papers 1
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Scripps Translational Science Institute and Scripps Health
Co-authored papers 1
Baylor College of Medicine
Co-authored papers 1
Broad Institute of Harvard and MIT
Co-authored papers 1
The University of Texas Health Science Center at Houston School of Dentistry
Co-authored papers 1
Cleveland Clinic.
Co-authored papers 1
David Geffen School of Medicine at University of California los angeles
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers 1
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1